Phillip E. Hoffsten

1.6k total citations
18 papers, 1.3k citations indexed

About

Phillip E. Hoffsten is a scholar working on Immunology, Nephrology and Physiology. According to data from OpenAlex, Phillip E. Hoffsten has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Nephrology and 4 papers in Physiology. Recurrent topics in Phillip E. Hoffsten's work include Renal Diseases and Glomerulopathies (3 papers), Biochemical effects in animals (3 papers) and Parathyroid Disorders and Treatments (2 papers). Phillip E. Hoffsten is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Biochemical effects in animals (3 papers) and Parathyroid Disorders and Treatments (2 papers). Phillip E. Hoffsten collaborates with scholars based in United States. Phillip E. Hoffsten's co-authors include J. Weinstein, F. Edmund Hunter, Janusz M. Gebicki, A. Scott, Mabel L. Purkerson, Saulo Klahr, A. Schneider, Eduardo Slatopolsky, Neal S. Bricker and Frank J. Dixon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Phillip E. Hoffsten

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip E. Hoffsten United States 13 423 336 232 176 148 18 1.3k
Anne P. Autor United States 23 785 1.9× 96 0.3× 213 0.9× 312 1.8× 268 1.8× 43 2.0k
Orhan Canbolat Türkiye 19 329 0.8× 102 0.3× 192 0.8× 179 1.0× 66 0.4× 39 1.2k
Radhakrishna Baliga United States 20 721 1.7× 655 1.9× 112 0.5× 189 1.1× 212 1.4× 52 2.3k
Munekazu Gemba Japan 20 497 1.2× 115 0.3× 90 0.4× 138 0.8× 122 0.8× 93 1.4k
Scott K. Howell United States 21 549 1.3× 163 0.5× 478 2.1× 103 0.6× 47 0.3× 33 2.1k
Jasmina Mimić-Oka Serbia 19 443 1.0× 165 0.5× 102 0.4× 156 0.9× 71 0.5× 45 1.0k
Joachim Ziegenhorn United States 13 358 0.8× 37 0.1× 221 1.0× 197 1.1× 89 0.6× 22 1.5k
Yohei Miyamoto Japan 20 507 1.2× 456 1.4× 173 0.7× 95 0.5× 87 0.6× 64 1.4k
K. Carr United States 11 212 0.5× 74 0.2× 119 0.5× 50 0.3× 112 0.8× 17 1.0k
Nelly E. Avissar United States 23 518 1.2× 74 0.2× 220 0.9× 732 4.2× 209 1.4× 40 1.7k

Countries citing papers authored by Phillip E. Hoffsten

Since Specialization
Citations

This map shows the geographic impact of Phillip E. Hoffsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip E. Hoffsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip E. Hoffsten more than expected).

Fields of papers citing papers by Phillip E. Hoffsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip E. Hoffsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip E. Hoffsten. The network helps show where Phillip E. Hoffsten may publish in the future.

Co-authorship network of co-authors of Phillip E. Hoffsten

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip E. Hoffsten. A scholar is included among the top collaborators of Phillip E. Hoffsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip E. Hoffsten. Phillip E. Hoffsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Purkerson, Mabel L., et al.. (1982). Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Thrombosis Research. 26(4). 227–240. 61 indexed citations
2.
Hoffsten, Phillip E., et al.. (1979). Reticuloendothelial and mesangial function in murine immune complex glomerulonephritis. Kidney International. 15(2). 144–159. 24 indexed citations
3.
Rosenbaum, Robert, Phillip E. Hoffsten, Robert Stanley, & Saulo Klahr. (1978). Use of computerized tomography to diagnose complications of percutaneous renal biopsy. Kidney International. 14(1). 87–92. 72 indexed citations
4.
Hill, Cynthia L., et al.. (1977). Studies of the Immunoglobulin Eluted from the Glomeruli of Mice Chronically Infected with Lymphocytic Choriomeningitis Virus. The Journal of Immunology. 119(2). 707–713. 2 indexed citations
5.
Hoffsten, Phillip E., et al.. (1977). T-cell deficiency in immune complex glomerulonephritis. Kidney International. 11(5). 318–326. 11 indexed citations
6.
Hoffsten, Phillip E., Michael B. A. Oldstone, & Frank J. Dixon. (1977). Immunopathology of adoptive immunization in mice chronically infected with lymphocytic choriomeningitis virus. Clinical Immunology and Immunopathology. 7(1). 44–52. 10 indexed citations
7.
Hoffsten, Phillip E., Cynthia L. Hill, & Donald C. Shreffler. (1976). Glomerular deposition of Ss protein in murine immune complex glomerulonephritis. Clinical Immunology and Immunopathology. 6(1). 47–50. 2 indexed citations
8.
Purkerson, Mabel L., Phillip E. Hoffsten, & Saulo Klahr. (1976). Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney International. 9(5). 407–417. 222 indexed citations
9.
Hoffsten, Phillip E., Cynthia L. Hill, & S Klahr. (1975). Studies of abluminuria and proteinuria in normal mice and mice with immune complex glomerulonephritis.. PubMed. 86(6). 920–30. 14 indexed citations
10.
Hoffsten, Phillip E. & Frank J. Dixon. (1974). Effect of Irradiation and Cyclophosphamide on Anti-KLH Antibody Formation in Mice. The Journal of Immunology. 112(2). 564–572. 20 indexed citations
11.
Hoffsten, Phillip E. & Frank J. Dixon. (1973). EFFECT OF IMMUNOSUPPRESSION ON CHRONIC LCM VIRUS INFECTION OF MICE. The Journal of Experimental Medicine. 138(4). 887–889. 10 indexed citations
12.
Slatopolsky, Eduardo, et al.. (1972). Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease. Kidney International. 1(1). 38–46. 19 indexed citations
13.
Slatopolsky, Eduardo, et al.. (1970). Parathyroid morphology in suppressible and nonsuppressible renal hyperparathyroidism.. PubMed. 23(5). 497–509. 23 indexed citations
14.
Slatopolsky, Eduardo, Phillip E. Hoffsten, Mabel L. Purkerson, & Neal S. Bricker. (1970). On the influence of extracellular fluid volume expansion and of uremia on bicarbonate reabsorption in man. Journal of Clinical Investigation. 49(5). 988–998. 65 indexed citations
15.
Hunter, F. Edmund, A. Scott, Phillip E. Hoffsten, et al.. (1964). Studies on the Mechanism of Ascorbate-induced Swelling and Lysis of Isolated Liver Mitochondria. Journal of Biological Chemistry. 239(2). 604–613. 116 indexed citations
16.
Hunter, F. Edmund, A. Scott, Phillip E. Hoffsten, et al.. (1964). Studies on the Mechanism of Swelling, Lysis, and Distintegration of Isolated Liver Mitochondria Exposed to Mixtures of Oxidized and Reduced Glutathione. Journal of Biological Chemistry. 239(2). 614–621. 124 indexed citations
17.
Hunter, F. Edmund, Janusz M. Gebicki, Phillip E. Hoffsten, J. Weinstein, & A. Scott. (1963). Swelling and Lysis of Rat Liver Mitochondria Induced by Ferrous Ions. Journal of Biological Chemistry. 238(2). 828–835. 383 indexed citations
18.
Hoffsten, Phillip E., F. Edmund Hunter, Janusz M. Gebicki, & J. Weinstein. (1962). Formation of “lipid peroxide” under conditions which lead to swelling and lysis of rat liver mitochondria. Biochemical and Biophysical Research Communications. 7(4). 276–280. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne P. Autor Breakdown of academic impact, for papers by Orhan Canbolat Breakdown of academic impact, for papers by Radhakrishna Baliga Breakdown of academic impact, for papers by Munekazu Gemba Breakdown of academic impact, for papers by Scott K. Howell Breakdown of academic impact, for papers by Jasmina Mimić-Oka Breakdown of academic impact, for papers by Joachim Ziegenhorn Breakdown of academic impact, for papers by Yohei Miyamoto Breakdown of academic impact, for papers by K. Carr Breakdown of academic impact, for papers by Nelly E. Avissar
Rankless by CCL
2026